RESUMEN
OBJECTIVES: To analyze the biological and clinical progression of the prostate cancer stage T1a. MATERIAL AND METHODS: Retrospective study of 44 patients diagnosed of T1a prostate carcinoma between 1985 and 2001. We value biological and clinical progression, time up to the progression, mortality for tumour reason and survival, with the following stratification: patients without initial treatment and patients treated by means of external radiotherapy or radical prostatectomía. RESULTS: Of all 44 patients biological progression was observed in 5 (11.36%) and clinical progression in 4 (9.09%). The mortality to 5 years for tumour reason was of 2 (4.54%). Of all 38 patients without initial treatment biological progression was observed in 5 (13.15%), in an average time of 25.8 months and clinical progression in 4 (10.52%), in an average time of 34.5 months. The mortality to 5 years was of 2 (5.26%). In all 6 patients to whom radical treatment carried out them progression was not observed and they all live. There are no statistically significant differences between both groups of patients (p = NS). CONCLUSIONS: The biological and clinical progression of the T1a prostate cancer is low, 11.36% and 9.09%, respectively. The mortality to 5 years is of 4.54%. Differences of survival do not exist, statistically significant, between treated and not treated.
Asunto(s)
Adenocarcinoma/fisiopatología , Neoplasias de la Próstata/fisiopatología , Adenocarcinoma/mortalidad , Adenocarcinoma/terapia , Anciano , Anciano de 80 o más Años , Progresión de la Enfermedad , Humanos , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/patología , Estadificación de Neoplasias , Antígeno Prostático Específico/sangre , Prostatectomía , Neoplasias de la Próstata/mortalidad , Neoplasias de la Próstata/terapia , Radioterapia Adyuvante , Estudios Retrospectivos , Tasa de SupervivenciaRESUMEN
Metanephric adenoma is a kidney tumour first identified in 1988 and classified within the group of nephroblastic tumours. It is described as a benign tumour with no capacity to become malignant or metastatic, predominant in women in a 2:1 ratio relative to men, and which can develop at any point in life. In most cases, it is incidentally found as a result of an abdominal ultrasound study for signs and symptoms unrelated to the kidney. Less commonly it presents with pain, polycythemia, haematuria or palpable mass. The key radiologic sign is calcification, which occurs in a statistically higher proportion than in any other renal neoplasia. From the pathoanatomical point of view, the tumour consists of small acinus separated by acellular stroma resembling the hamartomatous elements of nephroblastomatosis and Wilms' tumour. This paper contributes one case of metanephric adenoma, the first one in the national literature.